LONGATO, ENRICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.384
AS - Asia 4.471
EU - Europa 2.876
SA - Sud America 780
AF - Africa 727
Continente sconosciuto - Info sul continente non disponibili 182
OC - Oceania 88
Totale 15.508
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.874
SG - Singapore 1.397
IT - Italia 1.092
CN - Cina 728
VN - Vietnam 578
BR - Brasile 483
HK - Hong Kong 454
BD - Bangladesh 250
DE - Germania 186
IN - India 166
FR - Francia 163
PL - Polonia 163
GB - Regno Unito 156
CA - Canada 141
FI - Finlandia 137
SE - Svezia 105
NL - Olanda 101
RU - Federazione Russa 93
PT - Portogallo 85
AR - Argentina 79
TR - Turchia 77
ES - Italia 70
IQ - Iraq 67
JP - Giappone 67
BJ - Benin 63
MX - Messico 58
ID - Indonesia 57
ZA - Sudafrica 56
KR - Corea 50
PK - Pakistan 45
SA - Arabia Saudita 45
UA - Ucraina 44
PH - Filippine 43
EC - Ecuador 36
AU - Australia 34
CL - Cile 33
GR - Grecia 32
IE - Irlanda 32
CR - Costa Rica 30
JM - Giamaica 30
UZ - Uzbekistan 30
AT - Austria 28
CO - Colombia 27
NP - Nepal 27
GA - Gabon 26
IR - Iran 26
PE - Perù 26
AE - Emirati Arabi Uniti 25
CZ - Repubblica Ceca 25
NI - Nicaragua 25
PY - Paraguay 25
TN - Tunisia 25
AZ - Azerbaigian 24
IL - Israele 24
MY - Malesia 24
AL - Albania 23
BE - Belgio 23
EE - Estonia 23
EG - Egitto 23
LB - Libano 23
MA - Marocco 23
RO - Romania 23
DZ - Algeria 22
VE - Venezuela 22
GH - Ghana 21
HN - Honduras 21
KE - Kenya 21
MU - Mauritius 21
PS - Palestinian Territory 21
TT - Trinidad e Tobago 21
BW - Botswana 20
CH - Svizzera 20
DK - Danimarca 20
JO - Giordania 20
TW - Taiwan 20
CG - Congo 19
CI - Costa d'Avorio 19
DO - Repubblica Dominicana 19
ET - Etiopia 19
UG - Uganda 19
MD - Moldavia 18
GF - Guiana Francese 17
GT - Guatemala 17
HR - Croazia 17
KH - Cambogia 17
LV - Lettonia 17
SO - Somalia 17
UY - Uruguay 17
AO - Angola 16
CM - Camerun 16
MG - Madagascar 16
NC - Nuova Caledonia 16
PR - Porto Rico 16
SK - Slovacchia (Repubblica Slovacca) 16
TH - Thailandia 16
BZ - Belize 15
GE - Georgia 15
KG - Kirghizistan 15
LY - Libia 15
ML - Mali 15
Totale 14.637
Salva come PNG Salva come JPEG
Città #
San Jose 910
Ashburn 856
Singapore 820
Hong Kong 385
Santa Clara 259
Chandler 227
Fairfield 216
Los Angeles 189
Council Bluffs 185
Ho Chi Minh City 179
Beijing 152
Hanoi 144
New York 110
Bytom 108
Padova 108
Houston 99
The Dalles 99
Woodbridge 90
Seattle 89
Boardman 86
Wilmington 85
Cambridge 82
Helsinki 80
Milan 80
Munich 79
Chicago 76
Rome 68
Lauterbourg 65
Ann Arbor 63
Cotonou 62
Staranzano 55
Lisbon 52
Orem 50
São Paulo 50
Turin 43
Tokyo 42
Buffalo 41
Da Nang 41
Dallas 39
Turku 38
Venice 38
Phoenix 37
Warsaw 37
Atlanta 35
Des Moines 34
Hefei 34
Denver 33
Medford 33
Princeton 32
San Diego 32
Chennai 31
Johannesburg 31
Naples 29
Montreal 28
Stockholm 28
Tashkent 28
Padua 27
Toronto 27
Libreville 26
Poplar 26
Baghdad 25
Dublin 25
Brooklyn 24
Haiphong 24
Istanbul 24
Athens 23
Managua 23
Roxbury 23
Baku 22
London 22
Nuremberg 22
San José 22
Amsterdam 21
Florence 21
Guangzhou 21
San Francisco 21
Boston 20
Salt Lake City 20
Frankfurt am Main 19
Kampala 19
Amman 18
Kingston 18
Nairobi 18
Abidjan 17
Redondo Beach 17
Riga 17
Vienna 17
Lappeenranta 16
Montevideo 16
Santiago 16
Seoul 16
Accra 15
Antananarivo 15
Kuala Lumpur 15
Noumea 15
Panama City 15
Phnom Penh 15
Pune 15
Shanghai 15
Addis Ababa 14
Totale 7.889
Salva come PNG Salva come JPEG
Nome #
Exposure to DPP-4 inhibitors and COVID-19 among people with type 2 diabetes. A case-control study 342
Overview of iDPP@CLEF 2022: The Intelligent Disease Progression Prediction Challenge 316
Exploring the Use of Projecting Conflicting Gradients in Multi-task Neural Networks with an Application to Amyotrophic Lateral Sclerosis 311
Overview of iDPP@CLEF 2023: The Intelligent Disease Progression Prediction Challenge 311
DAVI: A Dataset for Automatic Variant Interpretation 305
The impact of clinical history on the predictive performance of machine learning and deep learning models for renal complications of diabetes 288
Baseline Machine Learning Approaches To Predict Amyotrophic Lateral Sclerosis Disease Progression 278
Overview of iDPP@CLEF 2024: The Intelligent Disease Progression Prediction Challenge 271
A practical perspective on the concordance index for the evaluation and selection of prognostic time-to-event models 271
Predicting clinical events characterizing the progression of amyotrophic lateral sclerosis via machine learning approaches using routine visits data: a feasibility study 265
Explainable Deep-Learning Model Reveals Past Cardiovascular Disease in Patients with Diabetes Using Free-Form Visit Reports 262
Artificial intelligence and statistical methods for stratification and prediction of progression in amyotrophic lateral sclerosis: A systematic review 252
Using Wearable and Environmental Data to Improve the Prediction of Amyotrophic Lateral Sclerosis and Multiple Sclerosis Progression: an Explorative Study 247
Improved long-term cardiovascular outcomes after intensive versus standard screening of diabetic complications: an observational study 246
Baseline Machine Learning Approaches To Predict Multiple Sclerosis Disease Progression 243
Dynamic Bayesian Networks and Transfer Learning Enable the Development of Deep Sequence-Based Models on Small-Sample Data 243
Intelligent Disease Progression Prediction: Overview of iDPP@CLEF 2022 241
Glycaemic variability-based classification of impaired glucose tolerance vs. type 2 diabetes using continuous glucose monitoring data 239
Deep-learning-based natural-language-processing models to identify cardiovascular disease hospitalisations of patients with diabetes from routine visits' text 231
Detecting Undiagnosed Diabetes: Proof-of-Concept Based on the Health-Information Exchange System of the Veneto Region (North-East Italy) 229
Intelligent Disease Progression Prediction: Overview of iDPP@CLEF 2024 220
Comparative renal outcomes of matched cohorts of patients with type 2 diabetes receiving SGLT2 inhibitors or GLP-1 receptor agonists under routine care 214
Simple Linear Support Vector Machine Classifier Can Distinguish Impaired Glucose Tolerance Versus Type 2 Diabetes Using a Reduced Set of CGM-Based Glycemic Variability Indices 211
Performance assessment across different care settings of a heart failure hospitalisation risk-score for type 2 diabetes using administrative claims 209
Exposure to dipeptidyl-peptidase 4 inhibitors and the risk of pneumonia among people with type 2 diabetes: Retrospective cohort study and meta-analysis 205
Better cardiovascular outcomes of type 2 diabetic patients treated with GLP-1 receptor agonists versus DPP-4 inhibitors in clinical practice 205
Sudden cardiac death after myocardial infarction: individual participant data from pooled cohorts 202
Cardiovascular effectiveness of human-based vs. exendin-based glucagon like peptide-1 receptor agonists: a retrospective study in patients with type 2 diabetes 200
Effect of Clinical History on Predictive Model Performance for Renal Complications of Diabetes 199
Management of type 2 diabetes with a treat-to-benefit approach improved long-term cardiovascular outcomes under routine care 198
Machine Learning Models Highlight the Impact of Pollution and Weather Patterns on Relapse Occurrence in Multiple Sclerosis Patients 196
Manual and automatic identification of ACMG evidence in scientific papers 194
IGT and T2D subjects automatically classified using a selection of CGM-based glycemic variability indices 194
Predicting Multiple Sclerosis Worsening Using Stratification-Based and Time-Dependent Variables Extracted from Routine Visits Data 192
Validation and recalibration of the Finnish Diabetes Risk Score on the older American population of the Health and Retirement Study 192
A Deep Learning Approach to Predict Diabetes' Cardiovascular Complications from Administrative Claims 192
The Long Path to Usable AI 192
Explainable AI-Driven Prognostic Models in ALS: Insights from the BRAINTEASER Project 191
Unveiling Trustworthy AI Challenges: Characterizing Prediction Reliability 191
Time-series analysis of multidimensional clinical-laboratory data by dynamic Bayesian networks reveals trajectories of COVID-19 outcomes 190
Expected accuracy of proximal and distal temperature estimated by wireless sensors, in relation to their number and position on the skin 189
Intelligent Disease Progression Prediction: Overview of iDPP@CLEF 2023 188
A CONSENSUS MODEL TO IMPROVE THE PREDICTION OF TYPE 2 DIABETES ONSET: VALIDATION ON THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS DATA 184
Selected Articles From The 18th Conference On Computational Intelligence Methods For Bioinformatics & Biostatistics: medical informatics and decision making 178
Predicting clinical outcomes of amyotrophic lateral sclerosis progression using logistic regression and deep-learning multilayer perceptron approaches 176
Support vector machine fed by CGM-based glycemic variability indices can distinguish between IGT and T2D subjects 175
Dealing with Data Scarcity in Rare Diseases: Dynamic Bayesian Networks and Transfer Learning to Develop Prognostic Models of Amyotrophic Lateral Sclerosis 174
Comparing Propensity Score-Based Methods in Estimating the Treatment Effect: A Simulation Study. 172
CGM-based glycemic variability indices allow accurate classification of IGT and T2D subjects 172
Cardiovascular outcomes of type 2 diabetic patients treated with SGLT-2 inhibitors versus GLP-1 receptor agonists in real-life 172
Addressing practical issues of predictive models translation into everyday practice and public health management: A combined model to predict the risk of type 2 diabetes improves incidence prediction and reduces the prevalence of missing risk predictions 171
Selected articles from the 17th International Conference on Computational Intelligence Methods for Bioinformatics and Biostatistics (CIBB 2021) 169
Outcomes of patients with type 2 diabetes treated with SGLT-2 inhibitors versus DPP-4 inhibitors. An Italian real-world study in the context of other observational studies 169
Exploring the Impact of Environmental Pollutants on Multiple Sclerosis Progression. 167
Diabetes diagnosis from administrative claims and estimation of the true prevalence of diabetes among 4.2 million individuals of the Veneto region (North East Italy) 166
Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk 165
Importance of Recalibrating Models for Type 2 Diabetes Onset Prediction: Application of the Diabetes Population Risk Tool on the Health and Retirement Study 164
Long-term cardiovascular outcome after intensive versus standard screening of diabetic complications: a real-word observational study 164
Prediction of Cardiovascular Complications in Diabetes from Pharmacy Administrative Claims 158
Ranking physiological, lifestyle and environmental risk factors for predicting type 2 diabetes onset 152
Improving Discrimination Performance in Artificial Intelligence Models for Rare Diseases: Strategies for Dealing with Data Scarcity 150
Time-resolved trajectory of glucose lowering medications and cardiovascular outcomes in type 2 diabetes: a recurrent neural network analysis 142
Cardiovascular outcomes after initiating GLP-1 receptor agonist or basal insulin for the routine treatment of type 2 diabetes: a region-wide retrospective study 141
Comparing the Predictive Power of Heart Failure Hospitalisation Risk Scores Across Different Care Settings 141
Computational Intelligence Methods for Bioinformatics and Biostatistics - 17th International Meeting, CIBB 2021, Virtual Event, November 15–17, 2021, Revised Selected Papers 133
Towards automatic ACMG evidence identification for variant interpretation 129
Comparing the Predictive Power of Heart Failure Hospitalisation Risk Scores in the Diabetic Outpatient Clinic and Primary Care Settings 127
Prevalence and impact of diabetes among people infected with SARS-CoV-2 123
Deviations from the ADA/EASD treatment algorithm is associated with higher cardiovascular events and death in type 2 diabetes under routine care 120
Long-term preservation of kidney function with SGLT-2 inhibitors versus comparator drugs in people with type 2 diabetes and chronic kidney disease 118
Recurrent Neural Network to Predict Renal Function Impairment in Diabetic Patients via Longitudinal Routine Check-up Data 114
Expected accuracy of proximal and distal temperature estimated by wireless sensors, in relation to their number and position on the skin 111
Preface 110
Selected articles from the 17th International Conference on Computational Intelligence Methods for Bioinformatics and Biostatistics (CIBB 2021) 110
The BRAINTEASER Datasets: Clinical, Wearable and Environmental Data for ALS & MS Progression Modeling 108
null 88
Characterization of Chronic Kidney Disease Progression in Patients with Diabetes via Group-Based Multi-Trajectory Modeling 87
The association of environmental exposure with multiple sclerosis severity score: A study based on sequential data modeling 86
Effectiveness of oral semaglutide versus empagliflozin for the management of type 2 diabetes. PIONEER-2 trial emulation with real-world data 82
HAPT2D: high accuracy of prediction of T2D with a model combining basic and advanced data depending on availability 82
Stratifying cardiovascular benefits from GLP-1RA: a multisource analysis of patient-level CVOT and real-world data using AI-driven methods 76
Clusters of Personal Environmental Exposure for Investigating Multiple Sclerosis and Amyotrophic Lateral Sclerosis Progression 62
Deep Learning Model Predicts Relapse Occurrence in Multiple Sclerosis Via Sequences of Environmental Data 44
Simulation-based comparison of propensity score methods for treatment effect estimation on real-world data 41
Generating longitudinal synthetic data in type 2 diabetes using dynamic Bayesian networks: A case study on the LEADER trial dataset 40
Evaluating propensity-score-based methods in treatment effect estimation: a simulation study 36
A Dynamic Bayesian Network Approach for Generating Synthetic Longitudinal Clinical Data: A Case Study on Long-Term Diabetes Outcomes 36
Environmental Personal Exposure Clusters to Investigate Multiple Sclerosis and Amyotrophic Lateral Sclerosis Progression 27
null 26
Treatment persistence drives estimator performance in longitudinal causal inference based on observational data: A simulation study 15
Totale 15.508
Salva come PNG Salva come JPEG
Categoria #
all - tutte 41.063
article - articoli 18.145
book - libri 0
conference - conferenze 0
curatela - curatele 1.490
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 636
Totale 61.334
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022354 0 0 0 33 25 34 30 50 32 10 20 120
2022/2023455 76 64 33 32 50 44 2 30 50 15 32 27
2023/2024557 26 54 55 42 24 58 49 77 33 38 59 42
2024/20252.322 51 230 101 102 255 72 162 136 216 110 388 499
2025/20269.393 482 571 1.093 1.467 1.089 404 1.201 748 909 588 476 365
2026/20271.640 476 440 475 249 0 0 0 0 0 0 0 0
Totale 15.508